This inventor holds 1 USPTO granted patent. Top assignee: Syngen Biotech Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Gilbert Aaron Lee and His Patent on ST7 for Immune Modulation
Introduction
Gilbert Aaron Lee is an inventor associated with Taipei, Taiwan. His work includes a patent describing the use of ST7 to modulate immunity and support antiviral ability.
Latest Patents
Lee is associated with 1 patent, titled “Use of ST7 for Modulating Immunity and Against Viruses.” The invention describes ST7, deposited under accession numbers BCRC911126 and DSM34255, as an active ingredient for modulating immunity. According to the patent description, administering an effective dose may increase cellular IL-12p40 expression, modulate gut microbiota, and raise the intestinal Firmicutes-to-Bacteroidetes ratio, with the aim of improving immunity and antiviral ability.
Career Highlights
Lee is associated with Syngen Biotech Co., Ltd. His patent reflects the company’s work in biotechnology and immune modulation.
Collaborations
Lee’s listed coworker is Yu-Lun Tsai. The available information identifies their professional association but does not specify further details about their collaboration.
Conclusion
Gilbert Aaron Lee’s patent focuses on ST7 as a potential means of modulating immune responses and supporting antiviral ability.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile